IP Holding Structures 2026: Where to Locate Your Intell...

Intellectual property box regimes let companies tax qualifying IP income at rates far below the headline corporate rate: 1.75% in Malta, 2.5% in Cyprus, 5.2% in Luxembourg. These numbers have attracted multinationals and tech companies for over a decade. But two forces are now squeezing IP boxes from opposite directions. The OECD's Modified Nexus Approach limits who can use them. Pillar Two's 15% global minimum tax threatens to override the rates entirely. The result is a landscape where IP boxes still work, but only for companies that understand both constraints.

How IP boxes work: the basic mechanics

An IP box (also called a patent box or innovation box) applies a reduced tax rate to income derived from qualifying intellectual property. The qualifying IP typically includes patents, copyrighted software, plant variety rights, and utility models. Trademarks and marketing IP are generally excluded, which catches companies off guard when they assume a brand licensing structure will qualify.

The reduced rate is applied as either a percentage deduction from qualifying income (Cyprus deducts 80%, Belgium deducts 85%) or a lower headline rate on that income class (UK's 10% patent box, Netherlands' 9% innovation box). The mechanical difference matters for planning but the economic effect is similar: taxable income from qualifying IP is reduced by 50% to 90% compared to the standard rate.

Current effective rates across key jurisdictions: Malta at 1.75% (through its refund system combined with IP exemptions), Cyprus at 2.5%, Hungary at 4.5%, Belgium at 4.44% to 5.1%, Luxembourg at 5.2% to 5.76%, Ireland at 6.25% through the Knowledge Development Box, the Netherlands at 9%, the UK at 10%, and Switzerland at 8.5% to 10% depending on canton. Newer entrants include Singapore (5%, 10%, or 15% tiers under the Intellectual Development Incentive, with a new 15% tier added from February 2025), Hong Kong (5% patent box introduced in 2024, transitional until July 2026), and Japan (approximately 14.7% effective rate under a new innovation box starting April 2025 with a 30% income deduction).

The nexus approach: who actually qualifies

The OECD's Modified Nexus Approach, agreed in 2015 under BEPS Action 5, is the gatekeeper for every compliant IP box regime. The core idea: a company can only benefit from an IP box to the extent that it actually performed the R&D that created the IP. Buying patents from a related company and parking them in a low-tax jurisdiction doesn't qualify.

The formula is: Qualifying Income = Total IP Income multiplied by (Qualifying R&D Expenditure times 1.3) divided by Total R&D Expenditure. Qualifying expenditure includes direct R&D costs incurred by the company itself and subcontracting costs paid to unrelated third parties. Costs excluded from the numerator include IP acquisition costs and payments to related parties for outsourced R&D. The 30% uplift on qualifying expenditure (capped at total expenditure) gives companies some headroom, but it doesn't rescue structures where most R&D is performed by a related entity elsewhere.

What this means in practice: a company that acquires IP from its parent, employs two people to "manage" it, and licenses it back to operating subsidiaries will get little or no benefit from an IP box. The nexus fraction will be close to zero because the qualifying expenditure (local R&D) is minimal relative to total expenditure (which includes the acquisition cost). The company that benefits most is one that performs genuine R&D locally, develops IP through its own employees, and earns licensing or product income from that IP.

Pillar Two: the 15% floor and its exceptions

The OECD/G20 Inclusive Framework's Pillar Two Global Anti-Base Erosion rules impose a 15% minimum effective tax rate on multinational groups with consolidated revenue of EUR 750 million or more. The first GloBE Information Returns are due by 30 June 2026 for fiscal years beginning on or after 31 December 2023. Any jurisdiction-level effective tax rate below 15% triggers a top-up tax, collected either by the low-tax jurisdiction itself (through a Qualified Domestic Minimum Top-up Tax) or by the parent jurisdiction (through the Income Inclusion Rule).

At first glance, this kills every IP box rate below 15%. Malta's 1.75%, Cyprus's 2.5%, Hungary's 4.5%: all would be topped up to 15% for in-scope groups. But two safety valves exist.

First, the Substance-Based Tax Incentive Safe Harbour (SBTI-SH) allows a carve-out based on tangible assets and payroll in the jurisdiction. For companies with genuine employees and physical presence, a portion of income is excluded from the GloBE calculation. This doesn't eliminate the top-up entirely, but it reduces it, particularly for companies with substantial local operations.

Second, Qualified Tax Incentives (QTIs) are designed to protect regimes that meet specific criteria: they must be based on substance and linked to specific new activities or investment. Whether a particular IP box qualifies as a QTI is still being worked out jurisdiction by jurisdiction. The OECD's guidance on QTIs remains incomplete, and companies are operating with significant uncertainty about which benefits will survive the GloBE framework.

Does Pillar Two matter for your company?

If your group's consolidated revenue is below EUR 750 million, you are not in scope for Pillar Two. Full stop. The vast majority of companies using IP box regimes are below this threshold. For these businesses, the IP box rates function exactly as advertised: Malta's 1.75%, Cyprus's 2.5%, and the rest remain available without any top-up.

But smaller companies should still pay attention for two reasons. First, the EUR 750 million threshold may decrease over time. Several jurisdictions and academic commentators have called for lowering it, and the Inclusive Framework has not ruled this out. Second, if your company is acquired by a larger group, the acquiring group's GloBE position could render your IP box structure inefficient overnight. Planning for an eventual exit or acquisition should factor in how the IP structure looks from the buyer's perspective.

Which jurisdictions still work?

For sub-EUR 750 million groups, the analysis is straightforward: choose based on nexus compliance, substance requirements, and the practical cost of establishing genuine R&D operations. Cyprus and Ireland offer strong combinations of low IP box rates, educated workforces, English-language legal systems, and developed service provider ecosystems. The Netherlands and Belgium suit companies with existing European operations that want to centralise IP in a jurisdiction with deep treaty networks. Hungary offers the lowest rate among established EU members (4.5%) but has a thinner advisory ecosystem.

For groups above EUR 750 million, the question shifts from "which rate is lowest" to "which regime delivers the best after-GloBE outcome." Ireland's 6.25% KDB rate, combined with its strong substance infrastructure and potential QTI protection, may outperform a nominally lower rate that gets topped up to 15%. Switzerland's cantonal regimes, with rates around 8.5% to 10%, sit close enough to 15% that the top-up is modest, and the substance carve-out for payroll and assets further reduces it for companies with real Swiss operations.

Japan's new innovation box (effective April 2025) is worth watching. At approximately 14.7% effective, it sits just below the Pillar Two floor and comes with a 30% income deduction on qualifying IP. For Japanese multinationals already performing R&D domestically, it may reduce the incentive to locate IP offshore at all, which is precisely the policy intent.

The substance question is the real one

Whether you are above or below the Pillar Two threshold, the nexus approach is the binding constraint. No amount of rate shopping helps if your company cannot demonstrate that qualifying R&D expenditure constitutes a meaningful share of total R&D costs. Before selecting a jurisdiction, map your R&D activities: where are the engineers? Where is code written, tested, and deployed? Where are patent applications filed? Where do the people who make technical decisions sit?

If the honest answer is "all our R&D happens in our home country," then an IP box in another jurisdiction is unlikely to deliver meaningful benefits under the nexus approach. The better strategy may be to use the home country's own R&D incentives (R&D tax credits, super-deductions, or domestic IP boxes where available) rather than constructing an offshore IP holding structure that fails the nexus test. The era of substance-free IP migration ended with BEPS Action 5. The companies that still benefit from IP boxes are those willing to put real people, real investment, and real R&D activity where the IP sits.